Biomarkers of disease are assuming an ever increasing role in the discovery and development of drugs
ICON has long recognised their importance in all phases of the development process and has built up significant expertise in biomarker development and analysis.
Working closely with sponsors, our global laboratory groups (Bioanalytical, Central and Imaging) and our Clinical Pharmacodynamics team lead the industry in biomarker research utilising the latest scientific innovation and state-of-the-art development platforms. ICON’s Imaging Core Laboratory is also an industry leader in the provision of imaging biomarkers that support drug development.
Spanning all phases of drug development- our experts work with sponsors to design and perform biomarker analysis that is customised to your development needs.
We will use our extensive experience to provide the most relevant experimental results to assess the functional activity or disposition potential of your compound or biologic.
- Custom development and validation
- Transferring of proprietary assays
- Commercial kit qualification
In this section
- Decentralised Clinical Trial Solutions
- Real World Intelligence
Cardiac Safety Monitoring
Clinical & Scientific Operations
- Clinical Operations
Clinical Supplies Management
- Clinical data science
Endpoint Adjudication Services
- Global Logistics
- Interactive Response Technology
- Investigator Payments
Medical Call Centre Services
Medical Writing & Publishing
Project and Program Management
Site Identification and Feasibility
- Early Clinical
- Language Services
- Medical Imaging
- Site & Patient Solutions
- Strategic Solutions
- Symphony Health
Decentralised Clinical Trial Solutions